Tonix Pharmaceuticals Holding Corp.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
NV
Business Address
200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
Mailing Address
200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
Phone
212-980-9155
Fiscal Year End
1231
EIN
261434750
Financial Overview
FY2025
$277.17M
Total Assets
$245.15M
Stockholders' Equity
$-14.57
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| 8-K Current report of material events | March 31, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | March 30, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 8-K Current report of material events | March 26, 2026 | View on SEC |
| 8-K Current report of material events | March 18, 2026 | View on SEC |
| 4 Insider stock transaction report | March 18, 2026 | View on SEC |
| 8-K Current report of material events | March 13, 2026 | View on SEC |
| 10-K Annual financial report | March 12, 2026 | View on SEC |
| 8-K Current report of material events | March 10, 2026 | View on SEC |
Annual Reports
10-K
March 12, 2026
- Advancing lead candidate TNX-102 SL in pivotal Phase 3 for fibromyalgia, with topline data expected early 2026.
- Diverse pipeline targeting CNS and immunology, including a smallpox/monkeypox vaccine candidate (TNX-801) with IND submitted.
Material Events
8-K
Financial Distress
March 18, 2026
High Impact
- New independent accounting firm, PricewaterhouseCoopers LLP (PwC), appointed.
- PwC's involvement could eventually lead to enhanced financial credibility and attract more investors.
Insider Trading
BUY
1 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.